集中式与分散式肺癌筛查项目在基线阴性人群中的依从性:美国队列研究的Meta分析
该Meta分析纳入12项美国队列研究共17,195例基线阴性者,比较集中式与分散式肺癌筛查的年度依从性。集中式项目汇总依从率为55%(95%CI 42%-58%),显著高于分散式(68.9% vs 37.1%;P<.0001),汇总OR为3.33(95%CI 1.92-5.78;中等确定性)。
要点
- 集中式筛查项目依从性显著高于分散式(68.9% vs 37.1%,P<.0001)。
- 集中式项目汇总依从率仅55%(95%CI 42%-58%),整体仍偏低。
- 依从性与患者及机构特征未见显著关联(P>.05,极低确定性)。
核心结论
- 集中式肺癌筛查项目的年度依从性显著高于分散式项目,但整体依从率仍偏低。
研究设计与样本
- 检索7个文献数据库,纳入2011年1月1日后发表的比较集中式与分散式肺癌筛查依从性的队列研究。
- 共纳入12项研究、17,195例基线筛查阴性者,采用随机效应模型进行Meta分析。
- 采用Newcastle-Ottawa量表进行质量评价,并用Meta回归分析依从性相关因素。
主要发现
- 集中式项目汇总依从率为55%(95%CI 42%-58%;12项研究,11,302例;随访10至18个月)。
- 集中式与分散式项目依从性分别为68.9%与37.1%,差异显著(P<.0001)。
- 配对Meta分析汇总OR为3.33(95%CI 1.92-5.78;4项研究,17,195例;中等确定性),异质性I2=98.3%(P<.0001)。
- Egger回归检验未提示发表偏倚(z=-0.374;P=.71)。
- 集中式项目依从性与Lung CT Screening Reporting & Data System分类、随访时长、年龄、性别、种族/民族、吸烟状态或机构类型均无显著关联(P>.05;极低确定性)。
关键数值与推荐
- 集中式项目汇总依从率55%(95%CI 42%-58%)。
- 集中式vs分散式依从性68.9% vs 37.1%(P<.0001),汇总OR 3.33(95%CI 1.92-5.78;中等确定性)。
- 配对分析异质性I2=98.3%(P<.0001)。
临床怎么用
- 可考虑扩大集中式肺癌筛查模式以提升年度依从性。
- 针对依从性偏低现状,应开展有针对性的质量改进措施。
局限性
- 配对Meta分析仅纳入4项研究,异质性极高(I2=98.3%)。
- 患者与机构层面因素分析确定性极低(very low certainty)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With rising interest in centralized lung cancer screening (LCS), synthesizing evidence to estimate its impact on annual adherence is critical for aligning practice with guideline recommendations. RESEARCH QUESTION: Is participation in a centralized screening program associated with higher adherence rates compared with decentralized programs among individuals with negative baseline LCS results? STUDY DESIGN AND METHODS: Seven bibliographic databases were searched for cohort studies published following January 1, 2011, reporting adherence outcomes for centralized vs decentralized LCS (primary outcome). Quality appraisal followed the Newcastle-Ottawa Scale for appraising observational studies. Random-effects meta-analysis was used to pool studies. Meta-regression examined patient- and institution-level characteristics associated with adherence in centralized programs. RESULTS: Twelve studies involving 17,195 patients with negative baseline results were included in this meta-analysis. The overall pooled adherence rate in centralized programs was 55% (95% CI, 42%-58%; 12 studies, 11,302 patients) with 10 to 18 months of follow-up. Adherence was significantly higher in centralized compared with decentralized screening programs (68.9% vs 37.1%; P < .0001), with a pooled OR of 3.33 (95% CI, 1.92-5.78; 4 studies, 17,195 patients; moderate certainty). Substantial heterogeneity was observed across the 4 studies in the pairwise meta-analysis (I2 = 98.3%; P < .0001). The Egger regression test showed no significant funnel plot asymmetry (z = -0.374; P = .71), suggesting no evidence of publication bias. No association was found between adherence in centralized LCS and Lung CT Screening Reporting & Data System category, follow-up duration, age, sex, race/ethnicity, smoking status, or institutional setting (P > .05; very low certainty). INTERPRETATION: Our results indicate that adherence to LCS remains low but is significantly higher in centralized screening programs compared with decentralized ones. Centralization may improve equity by addressing disparities associated with patient- and institution-level characteristics. These study findings support the expansion of centralized approaches and targeted quality improvement efforts to strengthen adherence to guideline-recommended LCS.
引用
- Ezenwankwo E, Jones C, Nguyen DT, et al. Lung Cancer Screening Adherence in Centralized vs Decentralized Screening Programs: A Meta-Analysis of US Cohort Studies Among Individuals With Negative Baseline Results. Chest. 2025. PMID: 40345524. doi:10.1016/j.chest.2025.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。